See also this year's filing and all EDGAR filings for this company.
PDF Report 0001442836_2020_Mersana_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001442836, Mersana Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 101,326,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,164,000 |
| 3 | remainder_Assets | 4,051,000 |
| 4 | LiabilitiesCurrent | 24,070,000 |
| 5 | LiabilitiesNoncurrent | 5,153,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 17,283,000 |
| 9 | ResearchAndDevelopmentExpense | 55,040,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 42,123,000 |
| 12 | remainder_NetIncome | 1,992,000 |
| 13 | remainder_ComprehensiveNetIncome | 33,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 107,541,000 |
| 1 | Liabilities | 29,223,000 |
| 2 | Expenses | 72,323,000 |
| 3 | Revenues | 42,123,000 |
| 4 | StockholdersEquity | 78,318,000 |
| 5 | NetIncome | -28,208,000 |
| 6 | ComprehensiveNetIncome | -28,191,500 |
| 7 | BaseVar | 126,617,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.08 |
| 9 | EconomicCapitalRatio | 3.08 |
Edgar->Model Mapping
Feature Distribution
Change over Time
